Research Article

CCL-2 and CXCL-8: Potential Prognostic Biomarkers of Acute Kidney Injury after a Bothrops atrox Snakebite

Figure 3

Ascendant signature of soluble immunological molecules presented by AKI(-) and AKI(+) patients. Performed based on the global median of each of the dosed cytokines and chemokines, using data from all patients (HD (healthy donors), AKI(-) without acute kidney injury, and AKI(+) with acute kidney injury). The global median of each molecule was used as a cut-off point, expressed in MFI (mean fluorescent intensity), thus classifying the individual as a “low” or “high” producer of the dosed molecules. Statistical significance was considered in all cases at . In the Venn diagram, it is possible to identify which molecules prove to be potential biomarkers because they are present in high concentrations only in the AKI(+) group.
(a)
(b)